Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.
Eur J Med Chem. 2024 Apr 5;269:116308. doi: 10.1016/j.ejmech.2024.116308. Epub 2024 Mar 11.
Eur J Med Chem. 2024.
PMID: 38503166
3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor.
Martinez M, Batista FA, Maurel M, Bouillon A, Ortega Varga L, Wehenkel AM, Le Chevalier-Sontag L, Blondel A, Haouz A, Hernandez JF, Alzari PM, Barale JC.
Martinez M, et al. Among authors: ortega varga l.
Acta Crystallogr D Struct Biol. 2023 Aug 1;79(Pt 8):721-734. doi: 10.1107/S2059798323004710. Epub 2023 Jul 10.
Acta Crystallogr D Struct Biol. 2023.
PMID: 37428845
Item in Clipboard
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.
Chen KY, Krischuns T, Ortega Varga L, Harigua-Souiai E, Paisant S, Zettor A, Chiaravalli J, Courtney D, O'Brien A, Baker SC, Isel C, Agou F, Jacob Y, Blondel A, Naffakh N.
Chen KY, et al. Among authors: ortega varga l.
bioRxiv [Preprint]. 2021 Dec 21:2021.12.18.473303. doi: 10.1101/2021.12.18.473303.
bioRxiv. 2021.
PMID: 34981051
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite